Editorial: Recent advancements in neoadjuvant chemotherapy for specific breast cancer subtypes

Editorial: Recent advancements in neoadjuvant chemotherapy for specific breast cancer subtypes

Bibliographic Details
Main Authors:	Sirin A. Adham, Myron R. Szewczuk, Fatima Mraiche, Emanuel Petricoin
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-12-01
Series:	Frontiers in Oncology
Subjects:	neoadjuvant chemotherapy TNBC conservative breast therapy cardiotoxicity breast cancer
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.1100427/full

Similar Items

A complex approach to continuous cardiac monitoring of neoadjuvant chemotherapy: Observational study
by: Yuri I. Buziashvili, et al.
Published: (2022-08-01)

BREAST-CONSERVING SURGERY AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS
by: A. R. Bosieva, et al.
Published: (2021-08-01)

Neoadjuvant chemotherapy for stage II–III breast cancer: a single-center experience
by: Haidi Abd El Zaher, et al.
Published: (2023-10-01)

Neoadjuvant chemotherapy for primary sarcoma of the breast: a case report
by: Chieko Miyazaki, et al.
Published: (2019-09-01)

Locoregional recurrence after neoadjuvant versus adjuvant chemotherapy based on tumor subtypes in patients with early-stage breast cancer: A multi-institutional retrospective cohort study
by: Jong-Ho Cheun, et al.
Published: (2024-12-01)

Locoregional recurrence and survival of breast−conserving surgery compared to mastectomy following neoadjuvant chemotherapy in operable breast cancer
by: Fa-you Lv, et al.
Published: (2024-03-01)

Breast-conserving surgery versus mastectomy for treatment of breast cancer after neoadjuvant chemotherapy
by: Yu-Chun Song, et al.
Published: (2023-07-01)

Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2015-05-01)

Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2015-05-01)

Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2015-05-01)

Relationship of Neoadjuvant Chemotherapy Efficacy with Histopathologic Molecular Subtypes in Breast Cancer Patients
by: Çiğdem Yıldırım, et al.
Published: (2024-11-01)

Surgical options of the breast and clinical outcomes of breast cancer patients after neoadjuvant chemotherapy: A single-center retrospective study
by: Yuting Sang, et al.
Published: (2022-10-01)

The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
by: Kai Conrad Cecil Johnson, et al.
Published: (2023-06-01)

Impact of various options of neoadjuvant chemotherapy on the hormonal status of patients with breast cancer
by: Yu. S. Sidorenko, et al.
Published: (2014-08-01)

Abbreviated breast MRI for evaluating breast cancer before initiation of neoadjuvant chemotherapy: A cross-sectional study
by: Arvin Arian, et al.
Published: (2023-12-01)

Study of feasibility and efficacy of neoadjuvant chemotherapy in cases of locally advanced breast cancer
by: Arun V Dawle, et al.
Published: (2015-01-01)

Outcomes of Triple-Negative Breast Cancer Patients in Response to Taxane and Nontaxane-Based Neoadjuvant Chemotherapies
by: Mohsin Khan, et al.
Published: (2022-06-01)

The role of carboplatin in the neoadjuvant chemotherapy treatment of triple negative breast cancer
by: Aurelio Bartolome Castrellon, et al.
Published: (2017-03-01)

Comprehensive assessment of the quality of life in patients with breast cancer during neoadjuvant chemotherapy
by: Yuri I. Buziashvili, et al.
Published: (2024-01-01)

Factors influencing pathological complete response and tumor regression in neoadjuvant radiotherapy and chemotherapy for high-risk breast cancer
by: Jan Haussmann, et al.
Published: (2024-07-01)

A study of the assessment of pathological response to neoadjuvant chemotherapy in patients with breast cancer
by: Supriya Mallige, et al.
Published: (2024-08-01)

Quantitative ultrasonography as a tool for the evaluation of breast tumor response to neoadjuvant chemotherapy
by: Piotrzkowska-Wróblewska Hanna, et al.
Published: (2022-04-01)

Invasive lobular carcinoma of the breast; clinicopathologic profile and response to neoadjuvant chemotherapy over a 15-year period
by: N.P. Quirke, et al.
Published: (2024-08-01)

Intraoperative and postoperative outcomes of Harmonic Focus versus monopolar electrocautery after neoadjuvant chemotherapy in breast conservative surgery: a comparative study
by: Islam Khaled, et al.
Published: (2021-11-01)

Machine learning for predicting breast-conserving surgery candidates after neoadjuvant chemotherapy based on DCE-MRI
by: Zhigeng Chen, et al.
Published: (2023-08-01)

Assessment of the Predictive Role of Ki-67 in Breast Cancer Patients’ Responses to Neoadjuvant Chemotherapy
by: Ghizlane Rais, et al.
Published: (2024-07-01)

EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy
by: Jonas Leichsenring, et al.
Published: (2022-10-01)

Moment of truth-adding carboplatin to neoadjuvant/adjuvant chemotherapy in triple negative breast cancer improves overall survival: An individual participant data and trial-level Meta-analysis
by: Neha Pathak, et al.
Published: (2022-08-01)

Impact of Atypical Hyperplasia at Surgical Margins on breast cancer outcomes in patients treated with neoadjuvant chemotherapy
by: An Su, et al.
Published: (2023-05-01)

Taxane combined with lobaplatin or anthracycline for neoadjuvant chemotherapy of triple-negative breast cancer: a randomized, controlled, phase II study
by: Cheng Wang, et al.
Published: (2024-06-01)

Differences in breast tumor response to neoadjuvant chemotherapy by race – Is obesity the key?
by: Ruvarashe Rumano, et al.
Published: (2024-12-01)

A radiomic model to classify response to neoadjuvant chemotherapy in breast cancer
by: Peter McAnena, et al.
Published: (2022-12-01)

The prognostic value of lymph node response to neoadjuvant therapy among breast cancer subtypes
by: Oana-Adriana RAJPUT-ANGHEL, et al.
Published: (2024-06-01)

Identification of the plasma total cfDNA level before and after chemotherapy as an indicator of the neoadjuvant chemotherapy response in locally advanced breast cancer
by: Ge Ma, et al.
Published: (2020-04-01)

Role of breast ultrasound, mammography, magnetic resonance imaging and diffusion weighted imaging in predicting pathologic response of breast cancer after neoadjuvant chemotherapy
by: Manal Hamisa, et al.
Published: (2015-03-01)

SYSTEMATIC REVIEW AND METAANALYSIS OF THE RESULTS OF BREAST-CONSERVING SURGERY AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS
by: A. R. Bosieva, et al.
Published: (2021-05-01)

Evaluation of Neoadjuvant Chemotherapy Response with Dynamic Contrast Enhanced Breast Magnetic Resonance Imaging in Locally Advanced Invasive Breast Cancer
by: Naciye Sinem Gezer, et al.
Published: (2014-04-01)

Accuracy of Breast Ultrasonography and Mammography in Comparison with Postoperative Histopathology in Breast Cancer Patients after Neoadjuvant Chemotherapy
by: Gilda Schmidt, et al.
Published: (2023-08-01)

Surgical outcomes following neoadjuvant chemotherapy with and without immunotherapy in patients with triple-negative breast cancer
by: Anouchka Coste Holt, et al.
Published: (2024-09-01)

Neoadjuvant chemotherapy for breast cancer: an evaluation of its efficacy and research progress
by: Yushi Chen, et al.
Published: (2023-10-01)